About the Authors

Mark Jolly
Brookes Batchelor LLP, London, United Kingdom

Anthony C. Fletcher
Salix Management Consultants Ltd, London, United Kingdom

Philip E. Bourne
Department of Pharmacology, University of California San Diego, La Jolla, California, United States of America

Philip E. Bourne
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, United States of America

Corresponding Author

pbourne@ucsd.edu

Competing Interests

The authors have declared that no competing interests exist.